Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

Breckenridge Pharmaceutical, Inc recalls Duloxetine Delayed-Release Capsules

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
Products
  • Duloxetine Delayed-Release Capsules
Where it was sold

Nationwide in the USA

Nationwide

Units affected
165,678, 90-count bottles
About this recall
Duloxetine Delayed-Release Capsules, USP, 60mg, 90-count bottle, Rx Only, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922. NDC 51991-748-90